A prospective, cumulative study of testosterone-undecanoate in hypogonadal men : An Observational registry record study

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

25 Sep 2020 Results assessing effects of long-term therapy with testosterone on liver metabolism and MACE over 11 years in men with hypogonadism and type 2 diabetes, presented at the 56th Annual Meeting of the European Association for the Study of Diabetes
18 Mar 2019 Results assessing the effect of Testosterone Undecanoate Injections in men with Hypogonadism and Osteoporosis (n=102), presented at the 101st Annual Meeting of the Endocrine Society
05 Oct 2018 Results assessing long-term testosterone therapy in hypogonadal men with T2DM (n=311) presented at the 54th Annual Meeting of the European Association for the Study of Diabetes

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com